Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers​", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Avershina E, Qureshi AI, Winther-Larsen HC, Rounge TB(2025) Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases Microbiome, 13(1), 66 DOI 10.1186/s40168-025-02048-3, PubMed 40055808
Hassan C, Bisschops R, Sharma P, Mori Y(2025) Colon Cancer Screening, Surveillance, and Treatment: Novel AI driving strategies in the management of colon lesions Gastroenterology(in press) DOI 10.1053/j.gastro.2025.02.021, PubMed 40054749
Trachsel-Moncho L, Veroni C, Mathai BJ, Lapao A, Singh S, Asp NT, Schultz SW, Pankiv S, Simonsen A(2025) SNX10 functions as a modulator of piecemeal mitophagy and mitochondrial bioenergetics J Cell Biol, 224(5) DOI 10.1083/jcb.202404009, PubMed 40052924